Abstract
Background: Chronic kidney disease (CKD) is a worldwide health problem, and the number of affected individuals is steadily increasing over time. It has been suggested that mesenchymal stem cells can be used as a novel treatment option for the management of CKD, based on encouraging data from rodent studies. Adipose-Derived (ADMSCs) are attractive sources of stem cells which have the capacity to differentiate into other cell types such as adipocytes, myocytes, osteoblasts, and neurons. Aim: The present study aimed to elucidate the potential role of adipose stem cells in the treatment of chronic kidney diseases. Oxidative stress was evaluated besides the histopathological findings. Subjects and Methods: Three groups of rats (10 rats each) were studied for 12 weeks after induction of CKD in 2 groups one of them treated with ADMSCs, Oxidative stress was measured in kidney tissue. Results: The oxidative stress capacity of the kidney was better in rats treated with ADMSCs than in the non-treated group. Histopathological examination revealed amelioration of renal tissue on treatment with adipose stem cells. Expression of mitochondrial DNA was also improved. Conclusion: ADMSCs can reduce the severity of the renal injury and prevent the progression of renal fibrosis after injury through suppressing oxidative stress
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
